What the INFORM-MS results do and don’t tell us => gavingiovannoni.substack.com/p/intranasal...
What the INFORM-MS results do and don’t tell us => gavingiovannoni.substack.com/p/intranasal...
A Phase 2 trial found that a lower dose of nasal foralumab significantly reduced brain inflammation markers in people with nonactive SPMS.
#MultipleSclerosis #MS
A Phase 2 trial found that a lower dose of nasal foralumab significantly reduced brain inflammation markers in people with nonactive SPMS.
#MultipleSclerosis #MS
Dans le cadre du PUI Innovation Alliance Université Paris-Saclay.
🔗 tinyurl.com/4dr5ufkd
Dans le cadre du PUI Innovation Alliance Université Paris-Saclay.
🔗 tinyurl.com/4dr5ufkd
https://bit.ly/3UH5dlE
https://bit.ly/3UH5dlE
lnkd.in/p/eP2a4SMx
lnkd.in/p/eP2a4SMx
cidadaospelaciberseguranca.com/2026/10/19/p...
cidadaospelaciberseguranca.com/2026/10/19/p...
It treats all....
Briumvi (ublituximab-xiiy
It is indicated for clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS).
It treats all....
Briumvi (ublituximab-xiiy
It is indicated for clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS).
Uma falha informática deixou esta segu...
📷 Draceane / Wikimedia Commons — CC BY-SA 4.0
Uma falha informática deixou esta segu...
📷 Draceane / Wikimedia Commons — CC BY-SA 4.0
Ler aqui artigo completo: healthnews.pt/2026/10/17/s...
#healthnews #saude #USF-AN
17.º Encontro Nacional das USF
Ler aqui artigo completo: healthnews.pt/2026/10/17/s...
#healthnews #saude #USF-AN
17.º Encontro Nacional das USF
AND, im a state advocate 🤦🏾♀️
AND, im a state advocate 🤦🏾♀️
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of SUN-627 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Impact on Measures of Neuroinflammation in the Central Nervous System in Pa...
#ClinicalTrials #MultipleSclerosis #MSchat #Neurology
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of SUN-627 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Impact on Measures of Neuroinflammation in the Central Nervous System in Pa...
#ClinicalTrials #MultipleSclerosis #MSchat #Neurology
https://www.stocktitan.net/news/TLSA/tiziana-announces-last-patient-completes-last-visit-in-phase-2a-ckm8mz72y58o.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/TLSA/tiziana-announces-last-patient-completes-last-visit-in-phase-2a-ckm8mz72y58o.html?utm_source=stocktitan-bluesky&utm_medium=social
CVE-2026-71801: An issue was discovered in s-pms SPMS-Server through v1.0
CVSS 9.8 · EPSS 0.2%
https://beta.vulnsea.com/cve/CVE-2026-71801
#CVE #infosec #cybersecurity #threatintel
CVE-2026-71801: An issue was discovered in s-pms SPMS-Server through v1.0
CVSS 9.8 · EPSS 0.2%
https://beta.vulnsea.com/cve/CVE-2026-71801
#CVE #infosec #cybersecurity #threatintel